HuGE Literature Finder
Records
1
-
11
| ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data. Radiation oncology (London, England) 2020 Jul 15 (1): 184. Kim Nalee, Kim Se Hoon, Kang Seok-Gu, Moon Ju Hyung, Cho Jaeho, Suh Chang-Ok, In Yoon Hong, Chang Jong H |
| Is There an Independent Role of TERT and NF1 in High Grade Gliomas? Translational oncology 2019 Dec 13 (2): 346-354. Razis Evangelia, Kotoula Vassiliki, Koliou Georgia-Angeliki, Papadopoulou Kyriaki, Vrettou Eleni, Giannoulatou Eleni, Tikas Ioannis, Labropoulos Stefanos V, Rigakos Georgios, Papaemmanoyil Styliani, Romanidou Ourania, Bourkoula Eugenia, Nomikos Panagiotis, Iliadis Georgios, Nasioulas George, Selviaridis Panagiotis, Polyzoidis Konstantinos, Fountzilas Geor |
| Predicting IDH genotype in gliomas using FET PET radiomics. Scientific reports 2018 Sep 8 (1): 13328. Lohmann Philipp, Lerche Christoph, Bauer Elena K, Steger Jan, Stoffels Gabriele, Blau Tobias, Dunkl Veronika, Kocher Martin, Viswanathan Shivakumar, Filss Christian P, Stegmayr Carina, Ruge Maximillian I, Neumaier Bernd, Shah Nadim J, Fink Gereon R, Langen Karl-Josef, Galldiks Norbe |
| TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data. Critical reviews in oncology/hematology 2017 Dec 120 1-9. Vuong Huy Gia, Altibi Ahmed M A, Duong Uyen N P, Ngo Hanh T T, Pham Thong Quang, Chan Aden Ka-Yin, Park Chul-Kee, Fung Kar-Ming, Hassell Lew |
| Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma. Neuro-oncology 2017 Aug . Suchorska Bogdana, Giese Armin, Biczok Annamaria, Unterrainer Marcus, Weller Michael, Drexler Mark, Bartenstein Peter, Schüller Ulrich, Tonn Jörg-Christian, Albert Nathalie |
| Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT. Acta neuropathologica 2017 Mar . Pekmezci Melike, Rice Terri, Molinaro Annette M, Walsh Kyle M, Decker Paul A, Hansen Helen, Sicotte Hugues, Kollmeyer Thomas M, McCoy Lucie S, Sarkar Gobinda, Perry Arie, Giannini Caterina, Tihan Tarik, Berger Mitchel S, Wiemels Joseph L, Bracci Paige M, Eckel-Passow Jeanette E, Lachance Daniel H, Clarke Jennifer, Taylor Jennie W, Luks Tracy, Wiencke John K, Jenkins Robert B, Wrensch Margaret |
| Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
| TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas. Oncotarget 2015 Jul . Zhang Zhen-Yu, Chan Aden Ka-Yin, Ding Xiao-Jie, Qin Zhi-Yong, Hong Christopher S, Chen Ling-Chao, Zhang Xin, Zhao Fang-Ping, Wang Yin, Wang Yang, Zhou Liang-Fu, Zhuang Zhengping, Ng Ho-Keung, Yan Hai, Yao Yu, Mao Yi |
| TERT promoter mutated WHO grades II and III gliomas are located preferentially in the frontal lobe and avoid the midline. International journal of clinical and experimental pathology 2015 8 (9): 11485-94. Sun Ze-Lin, Chan Aden Ka-Yin, Chen Ling-Chao, Tang Chao, Zhang Zhen-Yu, Ding Xiao-Jie, Wang Yang, Sun Chong-Ran, Ng Ho-Keung, Yao Yu, Zhou Liang- |
| TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations. British journal of cancer 2014 Nov 111 (10): 2024-32. Labussière M, Di Stefano A L, Gleize V, Boisselier B, Giry M, Mangesius S, Bruno A, Paterra R, Marie Y, Rahimian A, Finocchiaro G, Houlston R S, Hoang-Xuan K, Idbaih A, Delattre J-Y, Mokhtari K, Sanson |
| Secondary glioblastomas with IDH1/2 mutations have longer glioma history from preceding lower-grade gliomas. Brain tumor pathology 2013 Mar . Ohno M, Narita Y, Miyakita Y, Matsushita Y, Yoshida A, Fukushima S, Ichimura K, Shibui S |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: